ANNUL
发表于 2025-3-23 09:46:54
http://reply.papertrans.cn/25/2427/242689/242689_11.png
Ligneous
发表于 2025-3-23 16:32:40
https://doi.org/10.1007/978-3-642-73937-8d reductants which interfere with assay reading, reversal of antimetabolite assays, high salt concentrations in marine samples, and residual solvent in extracts, to name but a few. While all of the above-cited problems in getting reproducible data front natural products are important, the overwhelmi
oncologist
发表于 2025-3-23 21:03:56
https://doi.org/10.1007/978-3-642-73937-8with ionizing radiation at some time during the course of their disease (.). Thus, approximately 600,000 new patients will receive radiotherapy this year in the United States alone. Despite the proven efficacy of radiotherapy in the treatment of certain tumor types, nearly one half of the patients t
一条卷发
发表于 2025-3-24 00:56:29
http://reply.papertrans.cn/25/2427/242689/242689_14.png
概观
发表于 2025-3-24 04:49:05
http://reply.papertrans.cn/25/2427/242689/242689_15.png
眉毛
发表于 2025-3-24 06:35:26
http://reply.papertrans.cn/25/2427/242689/242689_16.png
失误
发表于 2025-3-24 11:49:02
https://doi.org/10.1007/978-3-642-73937-8-escalation scheme based on the optimally determined plasma concentration-versus-time (CXT) product in mouse models. Phase I human studies are initiated at a dose of onetenth the LD. in mice. Then, human pharmacology studies are conducted to determine plasma CXT data in patients. The dose is then es
maladorit
发表于 2025-3-24 15:42:25
http://reply.papertrans.cn/25/2427/242689/242689_18.png
一起
发表于 2025-3-24 21:14:36
http://reply.papertrans.cn/25/2427/242689/242689_19.png
整体
发表于 2025-3-25 01:32:25
https://doi.org/10.1007/978-3-642-73937-8 polypeptide hormones or growth factor sequences has resulted in the development of a new class of biological response modifier — the fusion toxin (.–.). The first of these fusion toxins, DAB.-IL-2, is currently in human Phase I clinical trials and the early results clearly domonstrate that this mol